# Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade

> **NCT04616235** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 30 (actual)

## Conditions studied

- Interleukin-6 Inhibition
- Physical Stress
- Appetitive Behavior

## Interventions

- **DRUG:** Tocilizumab Injectable Product
- **OTHER:** Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour

## Key facts

- **NCT ID:** NCT04616235
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2021-10-04
- **Final completion:** 2021-10-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04616235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04616235, "Acute Exercise and NK Cell Regulation in Tissue and Circulation After IL-6R Blockade". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04616235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*